Publication | Open Access
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
40
Citations
41
References
2024
Year
Breast OncologyMedicineClinical TrialsGynecologyPhase Ib TrialImmune Checkpoint InhibitorBreast CancerPharmacotherapyCancer TreatmentOncologyRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1